The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you
whenever you need it. Give us a call at
650-498-3333 or
PHYSICIAN HELPLINE
Have a question? We're here to help! Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
M. Peter Marinkovich, MD
Dermatologist, Blistering disease specialist, Cutaneous oncology specialist
Practice Areas
Professional Education
- Internship: UCSF House Staff Office (1989) CA
- Medical Education: St Louis University School of Medicine (1988) MO
- Residency: Oregon Health Science University (1994) OR
- Board Certification: Dermatology, American Board of Dermatology (1995)
- Fellowship: Shriner's Hospital - Portland (1990) OR
Administrative Appointments
- Member, Cancer Center, Stanford University School of Medicine (2004 - Present)
- Member, Medical Institutional Review Board 4, Stanford University School of Medicine (2005 - Present)
- Attending Physician, Dermatology Service, Palo Alto VA Medical Center (1995 - Present)
- Director, Blistering Disease Clinic, Department of Dermatology, Stanford University School of Medicine (1995 - Present)
- Founding Member/Core Investigator, Program in Epithelial Biology, Stanford University (1999 - Present)
- Member, Institute for Immunity, Transplantation and Infection (ITI) (2011 - Present)
Publications
-
Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis
Gao, J., DeRouen, M. C., Chen, C.-H., Nguyen, M., Nguyen, N. T., & Marinkovich, M. P. (2008). Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis. GENES & DEVELOPMENT, 22(15), 2111-2124. -
Targeting a tumor-specific laminin domain critical for human carcinogenesis
Tran, M., Rousselle, P., Nokelainen, P., Tallapragada, S., Nguyen, N. T., & Marinkovich, M. P. (2008). Targeting a tumor-specific laminin domain critical for human carcinogenesis. CANCER RESEARCH, 68(8), 2885-2894. -
A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation
Waterman, E. A., Sakai, N., Nguyen, N. T., Horst, B. Aj., Veitch, D. P., & Marinkovich, M. P. (2007). A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation. CANCER RESEARCH, 67(9), 4264-4270. -
Laminin 332 in squamous-cell carcinoma
Marinkovich, M. P. (2007). Laminin 332 in squamous-cell carcinoma. NATURE REVIEWS CANCER, 7(5), 370-380.
-
Type VII collagen is required for Ras-driven human epidermal tumorigenesis
Ortiz-Urda, S., Garcia, J., Green, C. L., Chen, L., Lin, Q., & Khavari, P. A. (2005). Type VII collagen is required for Ras-driven human epidermal tumorigenesis. SCIENCE, 307(5716), 1773-1776.
-
Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification
Fine, J.-D., Bruckner-Tuderman, L., Eady, R. Aj., Bauer, E. A., Bauer, J. W., & Zambruno, G. (2014). Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(6), 1103-1126.
-
Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification.
Fine, J.-D., Bruckner-Tuderman, L., Eady, R. Aj., Bauer, E. A., Bauer, J. W., & Zambruno, G. (2014). Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. Journal of the American Academy of Dermatology, 70(6), 1103-1126.
-
Somatic Correction of Junctional Epidermolysis Bullosa by a Highly Recombinogenic AAV Variant
Melo, S. P., Lisowski, L., Bashkirova, E., Zhen, H. H., Chu, K., & Oro, A. E. (2014). Somatic Correction of Junctional Epidermolysis Bullosa by a Highly Recombinogenic AAV Variant. MOLECULAR THERAPY, 22(4), 725-733.
-
Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology
Fortuna, G., Lozada-Nur, F., Pollio, A., Aria, M., Cepeda-Valdes, R., & Cesar Salas-Alanis, J. (2013). Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 42(10), 733-740.
-
Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: A multicenter development and reliability assessment
Fortuna, G., Chainani-Wu, N., Lozada-Nur, F., Aria, M., Cepeda-Valdes, R., & Cesar Salas-Alanis, J. (2013). Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: A multicenter development and reliability assessment. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 68(1), 83-92.
-
Keratinocyte-Targeted Expression of Human Laminin gamma 2 Rescues Skin Blistering and Early Lethality of Laminin gamma 2 Deficient Mice
Adair-Kirk, T. L., Griffin, G. L., Meyer, M. J., Kelley, D. G., Miner, J. H., & Senior, R. M. (2012). Keratinocyte-Targeted Expression of Human Laminin gamma 2 Rescues Skin Blistering and Early Lethality of Laminin gamma 2 Deficient Mice. PLOS ONE, 7(9).
-
A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: A real and separate nosological entity?
Fortuna, G., Cesar Salas-Alanis, J., Guidetti, E., & Marinkovich, M. P. (2012). A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: A real and separate nosological entity?. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 66(6), 988-994.
-
Keratinocyte-targeted expression of human laminin ?2 rescues skin blistering and early lethality of laminin ?2 deficient mice.
Adair-Kirk, T. L., Griffin, G. L., Meyer, M. J., Kelley, D. G., Miner, J. H., & Senior, R. M. (2012). Keratinocyte-targeted expression of human laminin ?2 rescues skin blistering and early lethality of laminin ?2 deficient mice. PloS one, 7(9).
-
Linear immunoglobulin A bullous dermatosis
Fortuna, G., & Marinkovich, M. P. (2012). Linear immunoglobulin A bullous dermatosis. CLINICS IN DERMATOLOGY, 30(1), 38-50.
-
Molecular organization of the basement membrane zone
Hashmi, S., & Marinkovich, M. P. (2011). Molecular organization of the basement membrane zone. CLINICS IN DERMATOLOGY, 29(4), 398-411.
-
Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation
DeRouen, M. C., Zhen, H., Tan, S. H., Williams, S., Marinkovich, M. P., & Oro, A. E. (2010). Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. BMC DEVELOPMENTAL BIOLOGY, 10.
-
Long-Term Type VII Collagen Restoration to Human Epidermolysis Bullosa Skin Tissue
Siprashvili, Z., Nguyen, N. T., Bezchinsky, M. Y., Marinkovich, M. P., Lane, A. T., & Khavari, P. A. (2010). Long-Term Type VII Collagen Restoration to Human Epidermolysis Bullosa Skin Tissue. HUMAN GENE THERAPY, 21(10), 1299-1310.
-
Clinical and immunological heterogeneity of canine subepidermal blistering dermatoses with anti-laminin-332 (laminin-5) auto-antibodies
Olivry, T., Bizikova, P., Dunston, S. M., Bond, R., Halliwell, R., & Marinkovich, M. P. (2010). Clinical and immunological heterogeneity of canine subepidermal blistering dermatoses with anti-laminin-332 (laminin-5) auto-antibodies. VETERINARY DERMATOLOGY, 21(4), 345-357.
-
Observations of Skin Grafts Derived from Keratinocytes Expressing Selectively Engineered Mutant Laminin-332 Molecules
Sakai, N., Waterman, E. A., Nguyen, N. T., Keene, D. R., & Marinkovich, M. P. (2010). Observations of Skin Grafts Derived from Keratinocytes Expressing Selectively Engineered Mutant Laminin-332 Molecules. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 130(8), 2147-2150.
-
Role of Dermal-Epidermal Basement Membrane Zone in Skin, Cancer, and Developmental Disorders
Ko, M. S., & Marinkovich, M. P. (2010). Role of Dermal-Epidermal Basement Membrane Zone in Skin, Cancer, and Developmental Disorders. DERMATOLOGIC CLINICS, 28(1), 1-?.
-
Loss of the Desmosomal Protein Perp Enhances the Phenotypic Effects of Pemphigus Vulgaris Autoantibodies
Nguyen, B., Dusek, R. L., Beaudry, V. G., Marinkovich, M. P., & Attardi, L. D. (2009). Loss of the Desmosomal Protein Perp Enhances the Phenotypic Effects of Pemphigus Vulgaris Autoantibodies. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 129(7), 1710-1718.
-
Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model
Liu, Z., Sui, W., Zhao, M., Li, Z., Li, N., & Diaz, L. A. (2008). Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model. JOURNAL OF AUTOIMMUNITY, 31(4), 331-338.
-
Bridging structure with function: Structural, regulatory, and developmental role of laminins
Tzu, J., & Marinkovich, M. P. (2008). Bridging structure with function: Structural, regulatory, and developmental role of laminins. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 40(2), 199-214.
-
Discovery of basement membrane components.
Marinkovich, M. P. (2008). Discovery of basement membrane components. journal of investigative dermatology, 128(E2), E3-4.
-
What's new in blistering disorders?
Chaudbari, P., & Marinkovich, M. P. (2007). What's new in blistering disorders?. CURRENT ALLERGY AND ASTHMA REPORTS, 7(4), 255-263.
-
Integrin beta 4 regulates migratory behavior of keratinocytes by determining laminin-332 organization
Sehgal, B. U., DeBiase, P. J., Matzno, S., Chew, T.-L., Claiborne, J. N., & Jones, J. Cr. (2006). Integrin beta 4 regulates migratory behavior of keratinocytes by determining laminin-332 organization. JOURNAL OF BIOLOGICAL CHEMISTRY, 281(46), 35487-35498.
-
beta 4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1
Pullar, C. E., Baier, B. S., Kariya, Y., Russell, A. J., Horst, B. Aj., & Isseroff, R. R. (2006). beta 4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1. MOLECULAR BIOLOGY OF THE CELL, 17(11), 4925-4935.
-
Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells
Culp, T. D., Budgeon, L. R., Marinkovich, M. P., Meneguzzi, G., & Christensen, N. D. (2006). Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. JOURNAL OF VIROLOGY, 80(18), 8940-8950.
-
Laminin-5 alpha 3 G4-5 inhibition ablates epidermal tumorigenesis through PI3K-Akt pathway inactivation but does not disrupt normal epithelial cohesion
Tran, M. M., Rousselle, P., Nokelainen, P., Nguyen, N., Keene, D. R., & Marinkovich, M. P. (2006). Laminin-5 alpha 3 G4-5 inhibition ablates epidermal tumorigenesis through PI3K-Akt pathway inactivation but does not disrupt normal epithelial cohesion. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 126, 24-24.
-
Overexpression of laminin-8 in human dermal microvascular endothelial cells promotes angiogenesis-related functions
Li, J., Zhou, L., Tran, H. T., Chen, Y., Nguyen, N. E., & Marinkovich, M. P. (2006). Overexpression of laminin-8 in human dermal microvascular endothelial cells promotes angiogenesis-related functions. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 126(2), 432-440.
-
A simplified laminin nomenclature
Aumailley, M., Bruckner-Tuderman, L., Carter, W. G., Deutzmann, R., Edgar, D., & Yurchenco, P. D. (2005). A simplified laminin nomenclature. MATRIX BIOLOGY, 24(5), 326-332.
-
Type VII collagen is required for cellular invasiveness in epidermal carcinogenesis
Ortiz-Urda, S., Garcia, J., Marinkovich, M., & Khavari, P. (2005). Type VII collagen is required for cellular invasiveness in epidermal carcinogenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 124(4), A25-A25.
-
Two distinct roles for the laminin-5 beta 3 chain in epidermal carcinogenesis and adhesion
Waterman, E. A., Ortiz-Urda, S., Nguyen, N. T., Veitch, D. P., Horst, B. A., & Marinkovich, M. P. (2005). Two distinct roles for the laminin-5 beta 3 chain in epidermal carcinogenesis and adhesion. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 124(4), A22-A22.
-
Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma
Arbiser, J. L., Fan, C. Y., Su, X. B., van Emburgh, B. O., Cerimele, F., & Marinkovich, M. P. (2004). Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 123(4), 788-790.
-
Identification of critical domains of beta 4 integrin and laminin-5 required for human SCC development
Horst, B. A., Nokelainen, P., Fincher, E. F., Nguyen, N. T., Russell, A. J., & Marinkovich, M. P. (2004). Identification of critical domains of beta 4 integrin and laminin-5 required for human SCC development. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 122(3), A19-A19.
-
Kinetics and specificity of Fas ligand induction in toxic epidermal necrolysis
Chang, H. Y., Cooper, Z. A., Swetter, S. A., & Marinkovich, M. P. (2004). Kinetics and specificity of Fas ligand induction in toxic epidermal necrolysis. ARCHIVES OF DERMATOLOGY, 140(2), 242-244.
-
Mature human thymocytes migrate on laminin-5 with activation of metalloproteinase-14 and cleavage of CD44
Vivinus-Nebot, M., Rousselle, P., Breittmayer, J. P., Cenciarini, C., Berrih-Aknin, S., & Bernard, A. (2004). Mature human thymocytes migrate on laminin-5 with activation of metalloproteinase-14 and cleavage of CD44. JOURNAL OF IMMUNOLOGY, 172(3), 1397-1406.
-
Autocrine laminin-5 ligates alpha 6 beta 4 integrin and activates RAC and NF kappa B to mediate anchorage-independent survival of mammary tumors
Zahir, N., Lakins, J. N., Russell, A., Ming, W. Y., Chatterjee, C., & Weaver, V. M. (2003). Autocrine laminin-5 ligates alpha 6 beta 4 integrin and activates RAC and NF kappa B to mediate anchorage-independent survival of mammary tumors. JOURNAL OF CELL BIOLOGY, 163(6), 1397-1407.
-
alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of alpha 3 beta 1 integrin
Russell, A. J., Fincher, E. F., Millman, L., Smith, R., Vela, V., & Marinkovich, M. P. (2003). alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of alpha 3 beta 1 integrin. JOURNAL OF CELL SCIENCE, 116(17), 3543-3556.
-
Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid
Chu, J., Bradley, M., & Marinkovich, M. P. (2003). Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. ARCHIVES OF DERMATOLOGY, 139(6), 813-815.
-
Laminin-10 is crucial for hair morphogenesis
Li, J., Tzu, J., Chen, Y., Zhang, Y. P., Nguyen, N. T., & Marinkovich, M. P. (2003). Laminin-10 is crucial for hair morphogenesis. EMBO JOURNAL, 22(10), 2400-2410.
-
Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin
Veitch, D. P., Nokelainen, P., McGowan, K. A., Nguyen, T. T., Nguyen, N. E., & Marinkovich, P. M. (2003). Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. JOURNAL OF BIOLOGICAL CHEMISTRY, 278(18), 15661-15668.
-
NF-kappa B blockade and oncogenic Ras trigger invasive human epidermal neoplasia
Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., & Khavari, P. A. (2003). NF-kappa B blockade and oncogenic Ras trigger invasive human epidermal neoplasia. NATURE, 421(6923), 639-643.
-
Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue
Ortiz-Urda, S., Lin, Q., Green, C. L., Keene, D. R., Marinkovich, M. P., & Khavari, P. A. (2003). Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. JOURNAL OF CLINICAL INVESTIGATION, 111(2), 251-255.
-
The first international consensus on mucous membrane pemphigoid - Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators
Chan, L. S., Ahmed, A. R., ANHALT, G. J., Bernauer, W., Cooper, K. D., & Zone, J. J. (2002). The first international consensus on mucous membrane pemphigoid - Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. ARCHIVES OF DERMATOLOGY, 138(3), 370-379.
-
Epidermolysis bullosa: new and emerging trends.
Pai, S., & Marinkovich, M. P. (2002). Epidermolysis bullosa: new and emerging trends. American journal of clinical dermatology, 3(6), 371-380.
-
Collagen XVII (BP180, BPAG2) is the most common epidermal basement membrane autoantigen in humans and other animals
Olivry, T., & Marinkovich, M. P. (2002). Collagen XVII (BP180, BPAG2) is the most common epidermal basement membrane autoantigen in humans and other animals. ADVANCES IN VETERINARY DERMATOLOGY, VOL 4, 4, 20-29.
-
Linear IgA bullous dermatosis
Guide, S. V., & Marinkovich, M. P. (2001). Linear IgA bullous dermatosis. CLINICS IN DERMATOLOGY, 19(6), 719-727.
-
A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions
Olivry, T., Dunston, S. M., Schachter, M., Xu, L. T., Nguyen, N., & Chan, L. S. (2001). A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions. JOURNAL OF AUTOIMMUNITY, 16(4), 411-421.
-
IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain
Egan, C. A., Reddy, E. D., Nie, Z. X., Taylor, T. B., Schmidt, L. A., & Zone, J. J. (2001). IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 116(2), 348-350.
-
Properties of the collagen type XVII ectodomain - Evidence for N- to C-terminal triple helix folding
Areida, S. K., Reinhardt, D. P., Muller, P. K., FIETZEK, P. P., Kowitz, J., & Notbohm, H. (2001). Properties of the collagen type XVII ectodomain - Evidence for N- to C-terminal triple helix folding. JOURNAL OF BIOLOGICAL CHEMISTRY, 276(2), 1594-1601.
-
Laminins and human disease
McGowan, K. A., & Marinkovich, M. P. (2000). Laminins and human disease. MICROSCOPY RESEARCH AND TECHNIQUE, 51(3), 262-279.
-
Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes
Schmidt, E., Reimer, S., Kruse, N., Jainta, S., Brocker, E. B., & Zillikens, D. (2000). Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 115(5), 842-848.
-
Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans
Olivry, T., Dunston, S. M., Fahey, M., Nguyen, N., & Marinkovich, M. P. (2000). Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans. VETERINARY PATHOLOGY, 37(4), 302-309.
-
Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen
Kawahara, Y., Zillikens, D., Yancey, K. B., Marinkovich, M. P., Nie, Z., & Nishikawa, T. (2000). Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen. JOURNAL OF DERMATOLOGICAL SCIENCE, 23(2), 93-102.
-
Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa
Pulkkinen, L., Marinkovich, M. P., Tran, H. T., Lin, L., Herron, G. S., & Uitto, J. (1999). Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 113(6), 1114-1118.
-
Reduced anchoring fibril formation and collagen VII immunoreactivity in feline dystrophic epidermolysis bullosa
Olivry, T., Dunston, S. M., & Marinkovich, M. P. (1999). Reduced anchoring fibril formation and collagen VII immunoreactivity in feline dystrophic epidermolysis bullosa. VETERINARY PATHOLOGY, 36(6), 616-618.
-
Update on inherited bullous dermatoses
Marinkovich, M. P. (1999). Update on inherited bullous dermatoses. DERMATOLOGIC CLINICS, 17(3), 473-?.
-
Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2)
Olivry, T., Chan, L. S., Xu, L., Chace, P., Dunston, S. M., & Marinkovich, M. P. (1999). Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2). VETERINARY PATHOLOGY, 36(4), 328-335.
-
Melanocytes adhere to and synthesize laminin-5 in vitro
Scott, G. A., Cassidy, L., Tran, H., Rao, S. K., & Marinkovich, M. P. (1999). Melanocytes adhere to and synthesize laminin-5 in vitro. EXPERIMENTAL DERMATOLOGY, 8(3), 212-221.
-
Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen
Chan, L. S., Lapiere, J. C., Chen, M., Traczyk, T., Mancini, A. J., & Marinkovich, M. P. (1999). Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. ARCHIVES OF DERMATOLOGY, 135(5), 569-573.
-
NC1 domain of type VII collagen binds to the beta 3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats
Chen, M., Marinkovich, M. P., Jones, J. Cr., O'Toole, E. A., Li, Y. Y., & Woodley, D. T. (1999). NC1 domain of type VII collagen binds to the beta 3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 112(2), 177-183.
-
Gene therapy for a lethal genetic blistering disease: a status report.
BAUER, E. A., Herron, G. S., Marinkovich, M. P., Khavari, P. A., & Lane, A. T. (1999). Gene therapy for a lethal genetic blistering disease: a status report. Transactions of the American Clinical and Climatological Association, 110, 86-92.
-
BP180 gene delivery in junctional epidermolysis bullosa
Seitz, C. S., Giudice, G. J., Balding, S. D., Marinkovich, M. P., & Khavari, P. A. (1999). BP180 gene delivery in junctional epidermolysis bullosa. GENE THERAPY, 6(1), 42-47.
-
Self-assembly of laminin isoforms
Cheng, Y. S., Champliaud, M. F., Burgeson, R. E., Marinkovich, M. P., & Yurchenco, P. D. (1997). Self-assembly of laminin isoforms. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(50), 31525-31532.
-
Hypoxia increases human keratinocyte motility on connective tissue
O'Toole, E. A., Marinkovich, M. P., Peavey, C. L., Amieva, M. R., FURTHMAYR, H., & Woodley, D. T. (1997). Hypoxia increases human keratinocyte motility on connective tissue. JOURNAL OF CLINICAL INVESTIGATION, 100(11), 2881-2891.
-
LAD-1 is absent in a subset of junctional epidermolysis bullosa patients
Marinkovich, M. P., Tran, H. H., Rao, S. K., Giudice, G. J., Balding, S., & BRUCKNERTUDERMAN, L. (1997). LAD-1 is absent in a subset of junctional epidermolysis bullosa patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 109(3), 356-359.
-
Immunodissection of the connective tissue matrix in human skin
Keene, D. R., Marinkovich, M. P., & Sakai, L. Y. (1997). Immunodissection of the connective tissue matrix in human skin. MICROSCOPY RESEARCH AND TECHNIQUE, 38(4), 394-406.
-
Laminin-5 inhibits human keratinocyte migration
OToole, E. A., Marinkovich, M. P., Hoeffler, W. K., FURTHMAYR, H., & Woodley, D. T. (1997). Laminin-5 inhibits human keratinocyte migration. EXPERIMENTAL CELL RESEARCH, 233(2), 330-339.
-
Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components - A potential role in epidermal-dermal adherence in human skin
Chen, M., Marinkovich, M. P., Veis, A., Cai, X. Y., Rao, C. N., & Woodley, D. T. (1997). Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components - A potential role in epidermal-dermal adherence in human skin. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(23), 14516-14522.
-
Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid
Chan, L. S., MAJMUDAR, A. A., Tran, H. H., Meier, F., SCHAUMBURGLEVER, G., & Marinkovich, M. P. (1997). Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 108(6), 848-853.
-
LAD-1 is a collagenous component of keratinocyte adhesion complexes which assembles into a high molecular weight complex and which has homology to BP180.
Tran, H. H., Schumann, H., Balding, S., Giudice, G. J., BRUCKNERTUDERMAN, L., & Marinkovich, M. P. (1997). LAD-1 is a collagenous component of keratinocyte adhesion complexes which assembles into a high molecular weight complex and which has homology to BP180. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 108(4), 289-289.
-
A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.
Zillikens, D., Kawahara, Y., Ishiko, A., Shimizu, H., Mayer, J., & Hashimoto, T. (1996). A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. journal of investigative dermatology, 106(6), 1333-1338.
-
LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells
Marinkovich, M. P., Taylor, T. B., Keene, D. R., Burgeson, R. E., & Zone, J. J. (1996). LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 734-738.
-
Laminin-B is a lamina, densa autoantigen ih oral pemphigoid.
Chan, L. S., MAJMUDAR, A. A., Tran, H. H., Meier, F., SCHAUMBURGLEVER, G., & Marinkovich, M. P. (1996). Laminin-B is a lamina, densa autoantigen ih oral pemphigoid. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 41-41.
-
LAD-1 is absent in a subset of generalized atrophic benign junctional epidermolysis bullosa patients
Marinkovich, M. P., Tran, H. H., Rao, S. K., Giudice, G. J., Balding, S., & BRUCKNERTUDERMAN, L. (1996). LAD-1 is absent in a subset of generalized atrophic benign junctional epidermolysis bullosa patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 281-281.
-
A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone
Zillikens, D., Kawahara, Y., Ishiko, A., Shimizu, H., Mayer, J., & Hashimoto, T. (1996). A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(3), 465-470.
-
PRENATAL-DIAGNOSIS OF HERLITZ JUNCTIONAL EPIDERMOLYSIS-BULLOSA BY AMNIOCENTESIS
Marinkovich, M. P., Meneguzzi, G., Burgeson, R. E., BLANCHETBARDON, C., Holbrook, K. A., & Ortonne, J. P. (1995). PRENATAL-DIAGNOSIS OF HERLITZ JUNCTIONAL EPIDERMOLYSIS-BULLOSA BY AMNIOCENTESIS. PRENATAL DIAGNOSIS, 15(11), 1027-1034.
-
ANTIBASEMENT MEMBRANE AUTOANTIBODIES IN PATIENTS WITH ANTI-EPILIGRIN CICATRICIAL PEMPHIGOID BIND THE ALPHA-SUBUNIT OF LAMININ-5
Kirtschig, G., Marinkovich, M. P., Burgeson, R. E., & Yancey, K. B. (1995). ANTIBASEMENT MEMBRANE AUTOANTIBODIES IN PATIENTS WITH ANTI-EPILIGRIN CICATRICIAL PEMPHIGOID BIND THE ALPHA-SUBUNIT OF LAMININ-5. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 105(4), 543-548.
-
A NEWLY IDENTIFIED 105-KD LOWER LAMINA-LUCIDA AUTOANTIGEN IS AN ACIDIC PROTEIN DISTINCT FROM THE 105-KD GAMMA-2 CHAIN OF LAMININ-5
Chan, L. S., Wang, X. S., Lapiere, J. C., Marinkovich, M. P., Jones, J. Cr., & Woodley, D. T. (1995). A NEWLY IDENTIFIED 105-KD LOWER LAMINA-LUCIDA AUTOANTIGEN IS AN ACIDIC PROTEIN DISTINCT FROM THE 105-KD GAMMA-2 CHAIN OF LAMININ-5. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 105(1), 75-79.
-
NECROLYTIC MIGRATORY ERYTHEMA WITHOUT GLUCAGONOMA IN PATIENTS WITH LIVER-DISEASE
Marinkovich, M. P., Botella, R., DATLOFF, J., & Sangueza, O. P. (1995). NECROLYTIC MIGRATORY ERYTHEMA WITHOUT GLUCAGONOMA IN PATIENTS WITH LIVER-DISEASE. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 32(4), 604-609.
-
THE MOLECULAR-GENETICS OF BASEMENT-MEMBRANE DISEASES
Marinkovich, M. P. (1993). THE MOLECULAR-GENETICS OF BASEMENT-MEMBRANE DISEASES. ARCHIVES OF DERMATOLOGY, 129(12), 1557-1565.
-
BASEMENT-MEMBRANE PROTEINS KALININ AND NICEIN ARE STRUCTURALLY AND IMMUNOLOGICALLY IDENTICAL
Marinkovich, M. P., Verrando, P., Keene, D. R., Meneguzzi, G., Lunstrum, G. P., & Burgeson, R. E. (1993). BASEMENT-MEMBRANE PROTEINS KALININ AND NICEIN ARE STRUCTURALLY AND IMMUNOLOGICALLY IDENTICAL. LABORATORY INVESTIGATION, 69(3), 295-299.
-
CELLULAR-ORIGIN OF THE DERMAL-EPIDERMAL BASEMENT-MEMBRANE
Marinkovich, M. P., Keene, D. R., RIMBERG, C. S., & Burgeson, R. E. (1993). CELLULAR-ORIGIN OF THE DERMAL-EPIDERMAL BASEMENT-MEMBRANE. DEVELOPMENTAL DYNAMICS, 197(4), 255-267.
-
Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients.
Meneguzzi, G., Marinkovich, M. P., Aberdam, D., Pisani, A., Burgeson, R., & Ortonne, J. P. (1992). Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients. Experimental dermatology, 1(5), 221-229.
-
THE DERMAL EPIDERMAL JUNCTION OF HUMAN SKIN CONTAINS A NOVEL LAMININ VARIANT
Marinkovich, M. P., Lunstrum, G. P., Keene, D. R., & Burgeson, R. E. (1992). THE DERMAL EPIDERMAL JUNCTION OF HUMAN SKIN CONTAINS A NOVEL LAMININ VARIANT. JOURNAL OF CELL BIOLOGY, 119(3), 695-703.
-
IDENTIFICATION AND PARTIAL-PURIFICATION OF A LARGE, VARIANT FORM OF TYPE-XII COLLAGEN
Lunstrum, G. P., McDonough, A. M., Marinkovich, M. P., Keene, D. R., Morris, N. P., & Burgeson, R. E. (1992). IDENTIFICATION AND PARTIAL-PURIFICATION OF A LARGE, VARIANT FORM OF TYPE-XII COLLAGEN. JOURNAL OF BIOLOGICAL CHEMISTRY, 267(28), 20087-20092.
-
THE ANCHORING FILAMENT PROTEIN KALININ IS SYNTHESIZED AND SECRETED AS A HIGH-MOLECULAR-WEIGHT PRECURSOR
Marinkovich, M. P., Lunstrum, G. P., & Burgeson, R. E. (1992). THE ANCHORING FILAMENT PROTEIN KALININ IS SYNTHESIZED AND SECRETED AS A HIGH-MOLECULAR-WEIGHT PRECURSOR. JOURNAL OF BIOLOGICAL CHEMISTRY, 267(25), 17900-17906.
-
SYNTHESIS OF CALELECTRINS AND CALPACTIN-I DURING CYTOCHALASIN MEDIATED CELL SPREADING INHIBITION
Hom, Y. K., Marinkovich, M. P., Lozano, J. J., & Rocha, V. (1989). SYNTHESIS OF CALELECTRINS AND CALPACTIN-I DURING CYTOCHALASIN MEDIATED CELL SPREADING INHIBITION. CELL CALCIUM, 10(3), 135-144.
-
BASAL LAMINA INHIBITION SUPPRESSES SYNTHESIS OF CALCIUM-DEPENDENT PROTEINS ASSOCIATED WITH MAMMARY EPITHELIAL-CELL SPREADING
Rocha, V., Hom, Y. K., & Marinkovich, M. P. (1986). BASAL LAMINA INHIBITION SUPPRESSES SYNTHESIS OF CALCIUM-DEPENDENT PROTEINS ASSOCIATED WITH MAMMARY EPITHELIAL-CELL SPREADING. EXPERIMENTAL CELL RESEARCH, 165(2), 450-460.
-
COLLAGEN-SYNTHESIS AND DEPOSITION DURING MAMMARY EPITHELIAL-CELL SPREADING ON COLLAGEN GELS
Marinkovich, M. P., & Rocha, V. (1986). COLLAGEN-SYNTHESIS AND DEPOSITION DURING MAMMARY EPITHELIAL-CELL SPREADING ON COLLAGEN GELS. JOURNAL OF CELLULAR PHYSIOLOGY, 128(1), 61-70.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Aug 2015
great doctor!
SHC Patient, Nov 2014
Dr. Marinkovich's care and treatment are exemplary.
SHC Patient, Nov 2014
I always feel blessing that I am receiving care from this provider.
SHC Patient, Jun 2014
Dr. Marinkovich responded to an email I sent on a holiday weekend - and followed up with two additional ones. AWESOME!
SHC Patient, Mar 2014
Dr. Marinkovich is very caring and sympathetic. I also have complete confidence in his abilities and would highly recommend him to others with a similar illness.
SHC Patient, Feb 2014
Good.
SHC Patient, Aug 2015
great doctor!
SHC Patient, Nov 2014
Dr. Marinkovich's care and treatment are exemplary.
SHC Patient, Nov 2014
I always feel blessing that I am receiving care from this provider.
SHC Patient, Jun 2014
Dr. Marinkovich responded to an email I sent on a holiday weekend - and followed up with two additional ones. AWESOME!
SHC Patient, Mar 2014
Dr. Marinkovich is very caring and sympathetic. I also have complete confidence in his abilities and would highly recommend him to others with a similar illness.
SHC Patient, Feb 2014
Good.